Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Comments

Loading...

ARK Genomic Revolution ETF Stock News

ARKGBATS

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

News

Holdings Dividends Short Interest

Latest ARK Genomic Revolution ETF News | BATS:ARKG | Benzinga

Get the latest news on ARK Genomic Revolution ETF stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on ARK Genomic Revolution ETF performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Tuesday, March 04, 2025

Cathie Wood's Monday Moves: Ark Buys Tempus AI Dip And Airbnb Spike— Goes Shopping For Coinbase Stock Amid Trump Tariff Crypto Meltdown
Shivdeep Dhaliwal

Saturday, March 01, 2025

Cathie Wood's Ark Invest Loads Up On Tempus AI, Archer Aviation, But Sells Twist Bioscience: Here Are Key Ark Trades This Friday
Rounak Jain

Wednesday, February 26, 2025

Cathie Wood Buys The Dip In Tempus AI, Coinbase But Sells Ark's Bitcoin ETF Shares Amid Crypto Meltdown
Shivdeep Dhaliwal

Tuesday, February 25, 2025

Rocket Lab, Kratos, Archer Aviation And More Earnings This Week Could Have A Big Impact On Cathie Wood's Ark ETFs
Chris Katje

Monday, February 24, 2025

NIH Funding Cuts To Spook Healthcare Stocks? RFK Jr's Confirmation At HHS Sparks Concerns Over Research Dollars, 'Causing Uncertainty,' Says Analyst
Rishabh Mishra

Saturday, February 22, 2025

Cathie Wood's Ark Invest Loads Up On Beam Therapeutics, Nu Holdings: Offloads MercadoLibre, Adaptive Biotechnologies
Rounak Jain

Saturday, February 15, 2025

Cathie Wood's Ark Invest Loads Up On Iridium, Twist Bioscience, Offloads Roku: Here Are Key Ark Trades This Friday
Rounak Jain

Monday, February 10, 2025

Tempus AI Executives Sell $20 Million In Stock As Cathie Wood Buys And Nancy Pelosi Eyes Options
Kaustubh Bagalkote

Saturday, February 08, 2025

Cathie Wood's Ark Invest Bets Big On Amazon, Roblox And Illumina While Trimming Palantir Stake After Alex Karp-Led Company Touched An All-Time High On Thursday
Rounak Jain

Saturday, February 01, 2025

Cathie Wood's Ark Invest Bets On Biotech With CRISPR Therapeutics Investment, Exits Roblox
Rounak Jain

Monday, January 27, 2025

ETFs Shine As S&P 500 Hits Record High: Top 5 ETFs With Best Gains From Last Week
Chandrima Sanyal

Thursday, January 23, 2025

Cathie Wood Sees Trump's Second Term Reviving IPO Market, Unlocking Opportunities In Biotech And AI Sectors
Kaustubh Bagalkote

Wednesday, January 22, 2025

Cathie Wood's Ark Invest Buys Into Defense And Energy Stocks Amid Trump's Inaugural Policies
Rounak Jain

Saturday, January 18, 2025

Cathie Wood's Ark Invest Is Betting Big On This AI Darling And No It's Not Nvidia
Rounak Jain

Tuesday, January 14, 2025

Cathie Wood's Ark Invest Trims Palantir Again As Peter Thiel Co-Founded Firm's Stock Tumbles Nearly 15% In 2025
Benzinga Neuro

Saturday, January 11, 2025

Cathie Wood's Ark Invest Loads Up On Intellia Therapeutics Which Laid Off Over A Quarter Of Its Workforce
Rounak Jain

Saturday, January 04, 2025

Cathie Wood's Ark Invest Books Profits On Hot AI Stock Palantir, Sells Bitcoin ETF Shares As BTC Starts 2025 On A Positive Note
Rounak Jain

Thursday, December 12, 2024

Cathie Wood's Ark Invest Trims Tesla Exposure Amid Searing Rally, Sells $21.8M Worth Of Stock — Bets On This AI Medical Company
Shivdeep Dhaliwal

Friday, November 29, 2024

Cathie Wood Sees Tesla As 'Largest AI Project On Earth' — Here's Why She's Not Worried About Tech Investments
Kaustubh Bagalkote

Wednesday, November 27, 2024

Cathie Wood Sees $400B Opportunity In Biologics — How Have Her Bets Fared?
Kaustubh Bagalkote

Tuesday, November 12, 2024

Schrödinger Scores Big Despite Q3 Miss As Novartis Collaboration Promises Billions In Milestones: Details
Lekha Gupta

Thursday, November 07, 2024

Cathie Wood's Wednesday Exodus: Moderna And Jack Dorsey's Block Stocks Get Dumped
Benzinga Neuro

Thursday, October 31, 2024

Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500
Chris Katje

Thursday, October 17, 2024

Cathie Wood Continues To Sell Shares Of Jack Dorsey's Bitcoin-Focused Company Block — Ark Also Dumps Moderna, Robinhood Stock
Benzinga Neuro

Friday, October 11, 2024

Cathie Wood's Ark Invest Dumps Over $9M In Moderna Stock — Even With Post-COVID Plans On The Table
Benzinga Neuro

Tuesday, August 06, 2024

Cathie Wood-Led Ark Invest Went Shopping For AMD, Tesla, Amazon, Coinbase, Robinhood, Meta And Palantir Shares Amid Market Crash On Monday
Benzinga Neuro

Friday, August 02, 2024

Cathie Wood's Ark Adds Over $19M Worth Of Moderna Shares After Thursday's 21% Plunge On Guidance Cut
Shanthi Rexaline

Thursday, July 11, 2024

Cathie Wood Touts Palantir, Coinbase And Roku As ARK's Flagship Fund Shifts Focus From Mag 6 Amid 'Whiff' Of Lower Interest Rates
Benzinga Neuro

Thursday, May 30, 2024

Cathie Wood-Led Ark Invest Cuts Robinhood Holdings Amid Bitcoin Dip, Keeps Selling Moderna Stock — Buys Palantir And AMD Shares
Benzinga Neuro

Wednesday, May 29, 2024

Cathie Wood's Ark Invest Scoops Up Shares Of AMD And Palantir — Dumps Moderna Stock Worth $4.4M
Benzinga Neuro

Monday, May 20, 2024

Investment Advisor Says 'Throwing Random Darts At Tickers' Would Beat ARKK As Cathie Wood's Flagship Fund Lags Far Behind Soaring Market: 'How Do They Do It?!'
Shanthi Rexaline

Sunday, May 05, 2024

Cathie Wood's Ark Invest Snaps Up $3.54M Worth Of Shares In This Biopharma Company Following Positive Obesity Pipeline Update
Shanthi Rexaline

Tuesday, April 23, 2024

Cathie Wood's Ark Empire Bleeds As Investor Outflows Spike: 'The Loyal Shareholders Have Become Frustrated'
Piero Cingari

Tuesday, April 16, 2024

Cathie Wood's Ark Invest Continues To Shed Coinbase, Nvidia Shares
Benzinga Neuro

Wednesday, April 10, 2024

Cathie Wood's Ark Buys Roku, Palantir And $1M Worth Of Stock In This Healthcare Company
Shanthi Rexaline

Tuesday, April 09, 2024

Cathie Wood's Ark Sheds Nearly $4M Nvidia Shares And Trims Position In This AI Peer
Shanthi Rexaline

Wednesday, March 27, 2024

Cathie Wood's Ark Invest Continues To Double Down On Moderna, Sells Nvidia Shares
Benzinga Neuro

Tuesday, March 26, 2024

Cathie Wood's Ark Takes Profits In Rallying Crypto Stocks, Trims Nvidia And This COVID-19 Play Further
Shanthi Rexaline

Friday, March 22, 2024

5 Technologies That Could Be Worth $220 Trillion By 2030, Cathie Wood's ARK Predicts: 'The Time Is Now'
Piero Cingari

Thursday, March 21, 2024

Is Cathie Wood Buying The Rumor? Ark More Than Doubles Stake In This COVID-19 Vaccine Maker Ahead Of Flurry Of Catalysts
Shanthi Rexaline

Thursday, March 14, 2024

Cathie Wood's Ark Invest Sells Coinbase Shares As Bitcoin Hits Yet Another All-Time New High, Buys Stock Of This Social Media Company
Benzinga Neuro

Wednesday, March 06, 2024

Cathie Wood-Led Ark Invest Sells $24M Of Coinbase Shares Amid Bitcoin Surge To New Highs; Continues Nvidia Sell-Off — Acquires Tesla, Palantir Stock
Benzinga Neuro

Thursday, February 29, 2024

Cathie Wood's Ark Invest Dumps $17M In Coinbase Shares As The Exchange Grappled With Disruption Amid Bitcoin Rally
Benzinga Neuro

Tuesday, February 27, 2024

Cathie Wood's Ark Invest Offloads $6.9M Worth of Coinbase, Robinhood Shares Each Amid Searing Bitcoin Rally — Nvidia Stock Also Shed
Benzinga Neuro

Friday, February 23, 2024

Here's How Much Cathie Wood, Ark Invest Flagship Fund Missed By Selling Nvidia Early
Chris Katje

Friday, February 16, 2024

Cathie Wood's Ark Sells Coinbase Shares Amid Bitcoin Rally Despite Surprise Quarterly Profit — Nvidia, Alphabet Stocks Also Shed
Benzinga Neuro

Friday, February 09, 2024

Cathie Wood Trims Nvidia, Shopify Stakes To Pump Whopping $40M Into Pinterest Despite Q4 Revenue Miss
Benzinga Neuro

Thursday, February 08, 2024

Cathie Wood's Ark Invest Sheds $2.8M Worth Of Nvidia Shares Amid AI Hype, Picks Up Robinhood Stock Worth $1.3M
Benzinga Neuro

Tuesday, February 06, 2024

Not Shy Of Buying The Dip, Cathie Wood's Ark Mops Up Over $11M Worth Of Shares In Tesla — Sells Nvidia Stock
Benzinga Neuro

Thursday, January 18, 2024

Cathie Wood's Ark Invest Sells $8.04M Worth of DraftKings Shares
Benzinga Neuro

Popular Channels

PreMarket Playbook
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved